The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers

BACKGROUND: Limited data exist on the real‐world costs of applying whole‐genome analysis (WGA) in a clinical setting. We estimated the costs of applying WGA to guide treatments for patients with advanced cancers and characterized how costs evolve over time. METHODS: The setting is the British Columb...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Mol Genet Genomic Med
Hlavní autoři: Weymann, Deirdre, Laskin, Janessa, Roscoe, Robyn, Schrader, Kasmintan A., Chia, Stephen, Yip, Stephen, Cheung, Winson Y., Gelmon, Karen A., Karsan, Aly, Renouf, Daniel J., Marra, Marco, Regier, Dean A.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5441418/
https://ncbi.nlm.nih.gov/pubmed/28546995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mgg3.281
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky